CA4 p.Arg219Ser
c.655C>A · rs121434551 · VCV17608
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9521 | likely pathogenic · top 8% in CA4 |
|---|---|---|
| REVEL | 0.686 | pathogenic-leaning |
| SaProt | LLR -15.63 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6 | GERP 2.1, phastCons 1 |
| Regional constraint | o/e 0.99 | unconstrained · MANE · 9,386 bp · p 0.89 · regional, not allelic |
| Overall | ||
| CADD | 27.8 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,486 |
| European (non-Finnish)grpmax | 0.000254% | 393,338 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CA4
- Protein
- p.Arg219Ser
- Coding
- c.655C>A
- MANE Select
- NM_000717
- dbSNP
- rs121434551
- Type
- single nucleotide variant
- Location
- chr17:60158357 (GRCh38)
- Gene constraint
- LOEUF 0.975 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 89.86 · 10 PDB
- Residue 219
- a disulfide bond; a UniProt-annotated variant site (in rp17; abolishes carbonate dehydratase activity; impaired slc4a4 cotransporter activity stimulation); the alpha-carbonic anhydrase domain; a β-strand
Disease context
retinitis pigmentosa 17 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Retinitis pigmentosa (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, Mitochondrial inheritance
- Onset
- Adolescent, Adult, Childhood
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- CA4 p.Arg219His Likely pathogenic ★ same residue
- CA4 p.Arg219Cys Uncertain significance ★ ⚠ same residue
- CA4 p.Gly87Glu Uncertain significance ★★ ⚠ same condition
- CA4 p.Pro227Leu Uncertain significance ★★ ⚠ same condition
- CA4 c.*59G>A Conflicting classifications of pathogenicity ★ same condition
- CA4 p.Arg14Trp Conflicting classifications of pathogenicity ★ ⚠ same condition
- CA4 p.Arg69His Conflicting classifications of pathogenicity ★ ⚠ same condition
- CA4 c.745-9C>G Uncertain significance ★★ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ca4-p-arg219ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown